Showing posts with label atypical antipsychotics zyprexa lilly. Show all posts
Showing posts with label atypical antipsychotics zyprexa lilly. Show all posts

Saturday, November 06, 2010

Dr Melissa DelBello speaks, but this time it's on YouTube


Sen. Charles Grassley's hall of shame: The chairman of the Senate Finance Committee raised the case of Dr. Melissa DelBello, a psychiatrist who got hundreds of thousands of dollars in travel expenses, consulting fees, and lecture payments from AstraZeneca. DelBello also happened to be lead author of a study that concluded kids did well on AstraZeneca's antipsychotic med Seroquel.

Here's the timeline: DelBello authored the study, published in 2002. In 2003, she got $100,000 from the drugmaker, or so she told the University of Cincinnati. In 2004, she reported $80,000. AstraZeneca's figures total $238,000.

Grassley was pretty peeved not only about the apparent conflict of interest--which AstraZeneca denied; DelBello wasn't available for comment--but also by the fact that DelBello also got NIH funding during the same period. University of Cincinnati said it applauds Grassley's "looking into this very important issue."


Read more: Seroquel researcher got cash from AZ - FiercePharma http://www.fiercepharma.com/story/seroquel-researcher-got-cash-from-az/2008-04-08#ixzz14TRkOmDR
Looks like Melissa is now also getting money from Lilly :  

http://projects.propublica.org/docdollars/payments/557430

Saturday, January 31, 2009

"It was a very clever sort of con"

"Almost the whole scientific community was conned into thinking — as a consequence of good marketing — that this was a different and better set of drugs. The evidence, as it's all added up, has shown this to be untrue." Dr. Peter Tyrer, a leading psychiatric researcher at Imperial College London

"We have been paying $16 billion a year instead of $2 billion a year for drugs that seem to be no better and might be worse." Douglas Leslie, a researcher at the Medical University of South Carolina

Read the article